BindingDB logo
myBDB logout
Compile Data Set for Download or QSAR

Found 1 hit Enz. Inhib. hit(s) with Target = 'Orexin receptor type 2' and Ligand = 'BDBM50260994'   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Orexin receptor type 2


(Homo sapiens (Human))
BDBM50260994
PNG
(CHEMBL4066977)
Show SMILES CC(C)[C@@H](Cn1ccc(n1)-c1ccc(F)cn1)N(C)C(=O)c1cc(C)ccc1-n1nccn1 |r|
Show InChI InChI=1S/C24H26FN7O/c1-16(2)23(15-31-12-9-21(29-31)20-7-6-18(25)14-26-20)30(4)24(33)19-13-17(3)5-8-22(19)32-27-10-11-28-32/h5-14,16,23H,15H2,1-4H3/t23-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 952n/an/an/an/an/an/a



Chemistry Laboratories, Taisho Pharmaceutical Co., Ltd., 1-403 Yoshino-cho, Kita-ku, Saitama 331-9530, Japan. Electronic address: a-futamura@so.taisho.co.jp.

Curated by ChEMBL


Assay Description
Antagonist activity at human OX2R expressed in CHO cells assessed as reduction in [Ala6,12]orexin-A-induced intracellular Ca2+ mobilization incubated...


Bioorg Med Chem 25: 5203-5215 (2017)


Article DOI: 10.1016/j.bmc.2017.07.051
BindingDB Entry DOI: 10.7270/Q2D50QD4
More data for this
Ligand-Target Pair